Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
South Asian Journal of Cancer|September 7, 2019
Palliative chemotherapy in carcinoma nasopharynxVijay M Patil, Amit Joshi, Vanita Noronha, et al.Lung Cancer Management|January 16, 2019
Curative intent therapy in oligometastatic lung cancer with an unresectable primary with N3 nodes: case report and review of the literatureVanita Noronha, Amit Joshi, Vijay M Patil, et al.Cancer Reports (Hoboken, N.J.)|August 15, 2020
A competing risk analysis of death patterns in male genitourinary cancerAtanu Bhattacharjee, Gaurav Roy, Atul Budukh, et al.South Asian Journal of Cancer|June 9, 2016
Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatinS B Dessai, S Chakraborty, T V S Babu, et al.Journal of Gastrointestinal Cancer|May 21, 2016
Efficacy and Safety of Induction Chemotherapy in Esophageal Cancer with Airway InvolvementVanita Noronha, Amit Joshi, Vijay M Patil, et al.Oral Oncology|May 10, 2025
Evaluating the prognostic value of tumor-derived circulating endothelial cells and their progenitors in platinum-refractory oral cancer patients for response to triple metronomic therapyNishaat Shaikh, Manish Pandey, Subhakankha Manna, et al.Oncotargets and Therapy|April 14, 2017
EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Amit Joshi, Saurabh Zanwar, Vanita Noronha, et al.Indian Journal of Cancer|August 8, 2018
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive casesSaurabh Zanwar, Vanita Noronha, Amit Joshi, et al.South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.South Asian Journal of Cancer|February 9, 2023
Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 InhibitorsAkhil Kapoor, Vanita Noronha, Vijay M Patil, et al.Pageof 9